Skip to content
Axcess News – Lifestyle
Author:
Biodesix, Inc.
Biodesix to Participate in Upcoming Investor Conferences
May 21, 2026
RideNow Group, Inc. Reports First Quarter 2026 Financial Results
May 15, 2026
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026
RideNow Group, Inc. to Report First Quarter 2026 Earnings on May 14, 2026
May 8, 2026
Biodesix Announces First Quarter 2026 Results and Highlights
May 4, 2026
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
April 20, 2026
Biodesix Recognized as a Top Workplace for Third Consecutive Year
April 9, 2026
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development
April 6, 2026
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
March 20, 2026
RideNow Group, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
March 10, 2026
1
2
Next Page
→